Introduction: Post-traumatic epilepsy (PTE) accounts for 10% to 20% of all symptomatic epilepsies and 5% of all forms of epilepsy, and drug resistance is reported in up to 45% of cases.
Areas Covered: This is a focused narrative review that discusses the available data on the current and new PTE treatments, giving particular attention to the last 10 years.
Expert Opinion: Despite the disappointing results of many antiseizure medications (ASMs) in preventing epileptogenicity, it is still unclear whether the early intervention could lead to different clinical phenotypes in terms, for example, of seizure severity, drug resistance and comorbidity patterns. The same applies to compounds targeting neuroinflammation, oxidative stress and neurotransmission modulation. The heterogeneity of etiologies leading to PTE has limited the investigation and implementation of specific interventions. New studies must focus on identifying common pathways and mechanisms shared by different etiological processes, identifying biomarkers, and validating animal models of epileptogenesis concerning PTE. Drug repurposing research will facilitate rapid translation into clinical research. Multitarget drug combinations will also receive increasing attention. In terms of non-pharmacological treatments, Vagus Nerve Stimulation seems to be a good option, while epilepsy surgery and Deep Brain Stimulation deserve further attention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/14737175.2025.2469041 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cerebral protective effect of acupuncture based on its regulative effect on programmed cell death.
Zhen Ci Yan Jiu
February 2025
Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Programmed cell death (PCD) in the brain occurs throughout the whole process of life, and abnormal PCD may be an important factor leading to encephalopathy. It has been demonstrated that acupuncture has a good cerebral protective effect in the treatment of epilepsy, Alzheimer's disease, Parkinson's disease, depression, anxiety, insomnia, migraine and other dozens of brain diseases, and possesses characteristics of multi-point, networking, two-way and holistic regulation. In the present paper, we sum up the protective effect of acupuncture therapy from 1) cell apoptosis (for example, improving post-surgery cognition impairment, traumatic brain injury and ischemic stroke by relieving mitochondrial damage, activating mitochondrial autophagy, increasing blood-brain barrier permeability, and thus reducing cell apoptosis ), 2) cell autophagy (for example, improving post-surgery cognition impairment, traumatic brain injury and ischemic stroke by relieving mitochondrial damage, activating mitochondrial autophagy, and increasing blood-brain barrier permeability, and thus reducing cell apoptosis), 3) pyroptosis (for example, inhibiting abnormally-activated inflammasomes, and caspase and gasdermin D activity to remit pyroptosis in the treatment of stroke, depression, Parkinson's disease, and Alzheimer's disease animal models), 4) ferroptosis (for instance, regulating iron ion metabolism, relieving lipid peroxidation damage, and thus playing a brain protection role in the treatment of ischemic and hemorrhagic stroke animal models), 5) necroptosis (inhibiting necrotic apoptosis mediated by receptor-interacting protein kinase 1 in intracerebral hemorrhage rats), and so on.
View Article and Find Full Text PDFEngrams across diseases: Different pathologies - unifying mechanisms?
Neurobiol Learn Mem
February 2025
University of Bonn, Faculty of Medicine, Institute of Experimental Epileptology and Cognition Research (IEECR), Cellular Neuropathology and Cognition Group, Venusberg-Campus 1/C76, 53127 Bonn, Germany; University Hospital Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany. Electronic address:
Memories are our reservoir of knowledge and thus, are crucial for guiding decisions and defining our self. The physical correlate of a memory in the brain is termed an engram and since decades helps researchers to elucidate the intricate nature of our imprinted experiences and knowledge. Given the importance that memories have for our lives, their impairment can present a tremendous burden.
View Article and Find Full Text PDFChronic outcomes after mild-moderate traumatic brain injury in adult seizure-prone (FAST) and seizure-resistant (SLOW) rats: A model for understanding genetic contributions to acquired epileptogenesis?
Epilepsy Behav
February 2025
Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Neurology, Alfred Health, Melbourne, VIC 3004, Australia; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, VIC 3050, Australia. Electronic address:
Post-traumatic epilepsy (PTE) is a common, serious, long-term complication of traumatic brain injury (TBI). However, only a minority of individuals will develop epilepsy after a TBI, and the contribution of genetic predisposition to the risk of acquired epilepsy warrants further exploration. In this study, we examined whether innate, genetically determined differences in seizure susceptibility between seizure-prone FAST and seizure-resistant SLOW rat strains would influence chronic behavioral and PTE outcomes after experimental TBI.
View Article and Find Full Text PDFImipramine, an Acid Sphingomyelinase Inhibitor, Promotes Newborn Neuron Survival in the Hippocampus After Seizure.
Cells
February 2025
Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea.
Epilepsy, a chronic neurological disorder, is triggered by various insults, including traumatic brain injury and stroke. Acid sphingomyelinase (ASMase), an enzyme that hydrolyzes sphingomyelin into ceramides, is implicated in oxidative stress, neuroinflammation, and neuronal apoptosis. Ceramides, which have pro-apoptotic properties, contribute to oxidative damage and lysosomal dysfunction, exacerbating neuronal injury.
View Article and Find Full Text PDFTreatment options for post-traumatic epilepsy: an update on clinical and translational aspects.
Expert Rev Neurother
February 2025
Department of Neurology, St George's University Hospital and City St George's University of London, London, UK.
Introduction: Post-traumatic epilepsy (PTE) accounts for 10% to 20% of all symptomatic epilepsies and 5% of all forms of epilepsy, and drug resistance is reported in up to 45% of cases.
Areas Covered: This is a focused narrative review that discusses the available data on the current and new PTE treatments, giving particular attention to the last 10 years.
Expert Opinion: Despite the disappointing results of many antiseizure medications (ASMs) in preventing epileptogenicity, it is still unclear whether the early intervention could lead to different clinical phenotypes in terms, for example, of seizure severity, drug resistance and comorbidity patterns.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!